Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercepharma.com

FiercePharma

Get the latest updates from FiercePharma directly as they happen.

Follow now 402 followers

Latest posts

Last updated about 2 hours ago

Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma

about 2 hours ago

With an FDA decision date looming for its Duchenne muscular dystrophy (DMD)...

Gilead cranks up Yeztugo first-year sales forecast to $1B on 'unprecedented launch trajectory'

about 2 hours ago

Gilead raised its previous guidance of $800 million in revenues from the...

Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild

about 2 hours ago

Daiichi Sankyo is poised to report significantly lower full-year profit for fiscal...

AbbVie’s Skyrizi beats out J&J’s Tremfya in in April drug ad spending leaderboard

about 3 hours ago

After losing the top spot in March to Johnson & Johnson’s immunology...

Johnson & Johnson launches ‘Generation Fine’ depression project

about 4 hours ago

You’ve heard of Gen Z, but now Johnson & Johnson wants you...

Revisiting Pharma’s tariff reality

about 4 hours ago

Fierce Pharma’s Fraiser Kansteiner catches up with KPMG’s Chris Young to discuss...

Fierce Pharma Asia—Summit’s surprise interim trial miss; UCB’s $2B Candid buy; J&J’s CAR-T cuts

about 5 hours ago

Summit's PD-1xVEGF study surprisingly missed its mark at an interim analysis. UCB...

GSK tees up a Modern Family for meningitis messaging

about 5 hours ago

GSK is teaming up with “Modern Family” stars Julie Bowen and Ty...

Pre-launch efforts linked to lasting drug awareness edge: report

about 8 hours ago

Cancer treatments with high levels of physician awareness at launch maintain their...

How many of these 7 ADC handling considerations are on your radar?

about 20 hours ago

From cytotoxic safety to cold chain control, ADC manufacturing faces new pressures...

Angelini finds Catalyst for its US growth ambitions with $4.1B buyout

1 day ago

With an eye on the lucrative U.S. market, Italy’s Angelini Pharma has...

The timing is right for psychedelics manufacturer Optimi Health's IPO

1 day ago

Last month, when Optimi Health kicked off an initial public offering of...